Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB CIPLA DR. REDDYS LAB/
CIPLA
 
P/E (TTM) x 19.8 32.6 60.9% View Chart
P/BV x 4.5 5.2 85.4% View Chart
Dividend Yield % 0.6 0.6 114.8%  

Financials

 DR. REDDYS LAB   CIPLA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
CIPLA
Mar-23
DR. REDDYS LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs4,6561,185 392.8%   
Low Rs3,788852 444.5%   
Sales per share (Unadj.) Rs1,481.4281.9 525.5%  
Earnings per share (Unadj.) Rs270.735.1 770.5%  
Cash flow per share (Unadj.) Rs345.749.7 696.3%  
Dividends per share (Unadj.) Rs40.008.50 470.6%  
Avg Dividend yield %0.90.8 113.5%  
Book value per share (Unadj.) Rs1,389.6289.2 480.4%  
Shares outstanding (eoy) m166.53807.15 20.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.83.6 78.9%   
Avg P/E ratio x15.629.0 53.8%  
P/CF ratio (eoy) x12.220.5 59.5%  
Price / Book Value ratio x3.03.5 86.3%  
Dividend payout %14.824.2 61.1%   
Avg Mkt Cap Rs m703,039822,164 85.5%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46638,301 121.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697227,531 108.4%  
Other income Rs m10,5555,121 206.1%   
Total revenues Rs m257,252232,653 110.6%   
Gross profit Rs m63,86048,079 132.8%  
Depreciation Rs m12,50211,721 106.7%   
Interest Rs m1,4281,095 130.4%   
Profit before tax Rs m60,48540,384 149.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,41212,029 128.1%   
Profit after tax Rs m45,07328,355 159.0%  
Gross profit margin %25.921.1 122.5%  
Effective tax rate %25.529.8 85.5%   
Net profit margin %18.312.5 146.6%  
BALANCE SHEET DATA
Current assets Rs m203,161168,051 120.9%   
Current liabilities Rs m85,72150,333 170.3%   
Net working cap to sales %47.651.7 92.0%  
Current ratio x2.43.3 71.0%  
Inventory Days Days7973 108.1%  
Debtors Days Days1077 1,647.9%  
Net fixed assets Rs m112,638117,318 96.0%   
Share capital Rs m8331,614 51.6%   
"Free" reserves Rs m230,571231,845 99.5%   
Net worth Rs m231,404233,460 99.1%   
Long term debt Rs m1,2780-   
Total assets Rs m315,799290,067 108.9%  
Interest coverage x43.437.9 114.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 99.6%   
Return on assets %14.710.2 145.0%  
Return on equity %19.512.1 160.4%  
Return on capital %26.617.8 149.8%  
Exports to sales %52.222.6 230.6%   
Imports to sales %16.88.9 189.4%   
Exports (fob) Rs m128,80351,516 250.0%   
Imports (cif) Rs m41,48420,202 205.3%   
Fx inflow Rs m128,80364,282 200.4%   
Fx outflow Rs m41,48420,202 205.3%   
Net fx Rs m87,31944,080 198.1%   
CASH FLOW
From Operations Rs m58,87532,377 181.8%  
From Investments Rs m-41,373-23,885 173.2%  
From Financial Activity Rs m-26,861-9,583 280.3%  
Net Cashflow Rs m-9,073-968 937.5%  

Share Holding

Indian Promoters % 26.7 13.4 198.4%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 47.3 50.0 94.6%  
FIIs % 28.6 25.7 111.2%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 66.5 87.2%  
Shareholders   257,794 425,731 60.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    DIVIS LABORATORIES    ZYDUS LIFESCIENCES    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Dr. Reddys vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Cipla Share Price Performance

Period Dr. Reddys Cipla S&P BSE HEALTHCARE
1-Day 2.40% 3.04% 1.48%
1-Month -3.64% 2.33% -0.45%
1-Year 36.75% 69.83% 62.30%
3-Year CAGR 11.08% 22.97% 18.28%
5-Year CAGR 17.91% 23.50% 19.86%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.